Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 336

1.

Molecular nitrogen in comet 67P/Churyumov-Gerasimenko indicates a low formation temperature.

Rubin M, Altwegg K, Balsiger H, Bar-Nun A, Berthelier JJ, Bieler A, Bochsler P, Briois C, Calmonte U, Combi M, De Keyser J, Dhooghe F, Eberhardt P, Fiethe B, Fuselier SA, Gasc S, Gombosi TI, Hansen KC, Hässig M, Jäckel A, Kopp E, Korth A, Le Roy L, Mall U, Marty B, Mousis O, Owen T, Rème H, Sémon T, Tzou CY, Waite JH, Wurz P.

Science. 2015 Apr 10;348(6231):232-5. doi: 10.1126/science.aaa6100. Epub 2015 Mar 19.

PMID:
25791084
2.

High natural killer cell number might identify stroke patients at risk of developing infections.

De Raedt S, De Vos A, Van Binst AM, De Waele M, Coomans D, Buyl R, De Keyser J.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e71. doi: 10.1212/NXI.0000000000000071. eCollection 2015 Apr.

3.

Cometary science. Time variability and heterogeneity in the coma of 67P/Churyumov-Gerasimenko.

Hässig M, Altwegg K, Balsiger H, Bar-Nun A, Berthelier JJ, Bieler A, Bochsler P, Briois C, Calmonte U, Combi M, De Keyser J, Eberhardt P, Fiethe B, Fuselier SA, Galand M, Gasc S, Gombosi TI, Hansen KC, Jäckel A, Keller HU, Kopp E, Korth A, Kührt E, Le Roy L, Mall U, Marty B, Mousis O, Neefs E, Owen T, Rème H, Rubin M, Sémon T, Tornow C, Tzou CY, Waite JH, Wurz P.

Science. 2015 Jan 23;347(6220):aaa0276. doi: 10.1126/science.aaa0276. Epub 2015 Jan 22.

PMID:
25613892
4.

Autonomic dysfunction in acute ischemic stroke: an underexplored therapeutic area?

De Raedt S, De Vos A, De Keyser J.

J Neurol Sci. 2015 Jan 15;348(1-2):24-34. doi: 10.1016/j.jns.2014.12.007. Epub 2014 Dec 8.

PMID:
25541326
5.

Cometary science. 67P/Churyumov-Gerasimenko, a Jupiter family comet with a high D/H ratio.

Altwegg K, Balsiger H, Bar-Nun A, Berthelier JJ, Bieler A, Bochsler P, Briois C, Calmonte U, Combi M, De Keyser J, Eberhardt P, Fiethe B, Fuselier S, Gasc S, Gombosi TI, Hansen KC, Hässig M, Jäckel A, Kopp E, Korth A, LeRoy L, Mall U, Marty B, Mousis O, Neefs E, Owen T, Rème H, Rubin M, Sémon T, Tzou CY, Waite H, Wurz P.

Science. 2015 Jan 23;347(6220):1261952. doi: 10.1126/science.1261952. Epub 2014 Dec 10.

PMID:
25501976
6.

RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions.

Estornes Y, Aguileta MA, Dubuisson C, De Keyser J, Goossens V, Kersse K, Samali A, Vandenabeele P, Bertrand MJ.

Cell Death Dis. 2014 Dec 4;5:e1555. doi: 10.1038/cddis.2014.523.

PMID:
25476903
7.

Single-subject classification of schizophrenia patients based on a combination of oddball and mismatch evoked potential paradigms.

Laton J, Van Schependom J, Gielen J, Decoster J, Moons T, De Keyser J, De Hert M, Nagels G.

J Neurol Sci. 2014 Dec 15;347(1-2):262-7. doi: 10.1016/j.jns.2014.10.015. Epub 2014 Oct 16.

PMID:
25454645
8.

Multiparity in women with multiple sclerosis causes less long-term disability: yes.

D'hooghe MB, De Keyser J.

Mult Scler. 2014 Oct;20(11):1432-4. doi: 10.1177/1352458514534105. No abstract available.

PMID:
25344546
9.

Feasibility of AmbulanCe-Based Telemedicine (FACT) study: safety, feasibility and reliability of third generation in-ambulance telemedicine.

Yperzeele L, Van Hooff RJ, De Smedt A, Valenzuela Espinoza A, Van Dyck R, Van de Casseye R, Convents A, Hubloue I, Lauwaert D, De Keyser J, Brouns R.

PLoS One. 2014 Oct 24;9(10):e110043. doi: 10.1371/journal.pone.0110043. eCollection 2014.

10.

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with apixaban.

De Smedt A, Cambron M, Nieboer K, Moens M, Van Hooff RJ, Yperzeele L, Jochmans K, De Keyser J, Brouns R.

Int J Stroke. 2014 Oct;9(7):E31. doi: 10.1111/ijs.12315. No abstract available.

PMID:
25231581
11.

Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.

Van Hooff RJ, Nieboer K, De Smedt A, Moens M, De Deyn PP, De Keyser J, Brouns R.

Clin Neurol Neurosurg. 2014 Oct;125:189-93. doi: 10.1016/j.clineuro.2014.08.011. Epub 2014 Aug 15.

PMID:
25171393
12.

Prehospital stroke care: limitations of current interventions and focus on new developments.

Yperzeele L, Van Hooff RJ, De Smedt A, Valenzuela Espinoza A, Van de Casseye R, Hubloue I, De Keyser J, Brouns R.

Cerebrovasc Dis. 2014;38(1):1-9. doi: 10.1159/000363617. Epub 2014 Aug 6.

13.

β₂-adrenergic receptors protect axons during energetic stress but do not influence basal glio-axonal lactate shuttling in mouse white matter.

Laureys G, Valentino M, Demol F, Zammit C, Muscat R, Cambron M, Kooijman R, De Keyser J.

Neuroscience. 2014 Sep 26;277:367-74. doi: 10.1016/j.neuroscience.2014.07.022. Epub 2014 Jul 24.

PMID:
25064060
14.

Reduced information processing speed as primum movens for cognitive decline in MS.

Van Schependom J, D'hooghe MB, Cleynhens K, D'hooge M, Haelewyck MC, De Keyser J, Nagels G.

Mult Scler. 2015 Jan;21(1):83-91. doi: 10.1177/1352458514537012. Epub 2014 Jul 10.

PMID:
25013149
15.

The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.

Van Schependom J, D'hooghe MB, Cleynhens K, D'hooge M, Haelewyck MC, De Keyser J, Nagels G.

Eur J Neurol. 2014 Sep;21(9):1219-25, e71-2. doi: 10.1111/ene.12463. Epub 2014 May 22.

PMID:
24850580
16.

Intracranial artery dissection.

Sikkema T, Uyttenboogaart M, Eshghi O, De Keyser J, Brouns R, van Dijk JM, Luijckx GJ.

Eur J Neurol. 2014 Jun;21(6):820-6. doi: 10.1111/ene.12384. Epub 2014 Feb 22. Review.

PMID:
24824740
17.

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.

van Hooff RJ, Nieboer K, De Smedt A, Yperzeele L, Jochmans K, De Keyser J, Brouns R.

Clin Neurol Neurosurg. 2014 Jul;122:133-4. doi: 10.1016/j.clineuro.2013.12.029. Epub 2014 Apr 13. No abstract available.

PMID:
24813326
18.

Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection.

Van Schependom J, Gielen J, Laton J, D'hooghe MB, De Keyser J, Nagels G.

Neuroimage Clin. 2014 Jan 31;4:403-10. doi: 10.1016/j.nicl.2014.01.012. eCollection 2014.

19.

β₂-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations.

Laureys G, Gerlo S, Spooren A, Demol F, De Keyser J, Aerts JL.

J Neuroinflammation. 2014 Jan 30;11:21. doi: 10.1186/1742-2094-11-21.

20.

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Cambron M, Mostert J, Haentjens P, D'Hooghe M, Nagels G, Willekens B, Heersema D, Debruyne J, Van Hecke W, Algoed L, De Klippel N, Fosselle E, Laureys G, Merckx H, Van Wijmeersch B, Vanopdenbosch L, Verhagen W, Hupperts R, Hengstman G, Michiels V, Van Merhaegen-Wieleman A, De Keyser J.

Trials. 2014 Jan 25;15:37. doi: 10.1186/1745-6215-15-37.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk